Phelan McDermid Syndrome Foundation

Analysis

Phelan McDermid Syndrome Foundation is a registered charity in United States, based in Osprey, FL. It received its IRS tax-exemption ruling in April 2003, 23 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Phelan McDermid Syndrome Foundation reported income of $1.1m and spending of $1.1m, spending 103% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $656k to $1.1m (+62%), an average of +13% a year. The sharpest change came in the year to December 2021, when income rose by 60%. Over the whole period it spent 83% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Phelan McDermid Syndrome Foundation sits at the 65th percentile: it is larger than about 65% of them. Against every charity in United States with reported income it ranks in the 80th percentile, and in the 82nd percentile within FL. Charities of a similar size with the same main cause include Cancer Support Community Greater Ny & CT Inc ($1.1m), Brain Cancer Research Institute ($1.1m) and Carereach Inc ($1.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 79% and program service revenue 10% of the total. Compensation of current officers, directors and key employees was $117k (11% of expenses). Other salaries and wages came to $355k. At year end it held assets of $2.2m against liabilities of $216k, net assets of $2.0m. It reported 11 employees.